2006
- NBI Development Closes $5.5M Seed Financing - December 4, 2006
- IDev Technologies Closes $19M Financing - November 15, 2006
- PTC Announces Positive Phase 2 Results for PTC124 in Cystic Fibrosis - November 3, 2006
- Braincells And Organon Collaborate In Development Of CNS Drugs - October 23, 2006
- PTC Announces $17.2M Award From US Defense Threat Reduction Agency - October 2, 2006
- Astellas to Screen Another Target from Metabolex Gene Database - September 12, 2006
- Epocrates Celebrates Second Consecutive Year on Inc. 500 List - September 9, 206
- BrainCells In-licenses Clinical-stage CNS Compound From Mitsubishi Pharma - August 10, 2006
- Calypso Receives 510(K) Clearance For The Calypso 4d Localization System - August 8, 2006
- EnteroMedics Closes $45.2M Series C Financing - July 19, 2006
- Metabolex Enters Into an Agreement With Ortho-McNeil - June 26, 2006
- NeoRx Initiates Clinical Trial; Announces Name Change to Poniard Pharmaceuticals - May 10, 2006
- Aqua Bounty Technologies Completes £20M Placing - March 15, 2006
- Genospectra Acquires Panomics - February 10, 2006
- MAP Pharmaceuticals Closes $25.25M Series C Financing - January 25, 2006
2005
- PTC Therapeutics Raises $26.6M Private Financing - November 10, 2005
- Syntonix and Boehringer Ingelheim Enter Into Collaboration - October 21, 2005
- Reliant Pharmaceuticals Announces US Launch of Omacor - October 5, 2005
- BioRen Acquired by Pfizer - August 15, 2005
- EnteroMedics Enters Into R&D Agreement with Mayo Clinic - August 10, 2005
- VIA Pharmaceuticals In-licenses Compound From Abbott - August 10, 2005
- Metabolex Announces Final Phase II Results for Metaglidasen - June 10, 2005
- Amerifit Nutrition Acquired by Charterhouse Group - June 1, 2005
- Phenomix Closes Series B Financing at $40M - May 24, 2005
- Epocrates: 2004 a Rapid Growth Year - March 9, 2005
- Itamar Medical Announces FDA Approval of WatchPAT - March 3, 2005
- BioSeek Achieves Milestone in Collaboration with Dynavax - March 2, 2005
- Syrrx to be Acquired by Takeda - February 7, 2005
2004
- Nanogen and Epoch Biosciences Complete Merger - December 17, 2004
- SemBioSys Completes Initial Public Offering - December 12, 2004
- EnteroMedics Closes $16.9M Series B Financing - November 30, 2004
- Metabolex Raises $44M in Private Financing - November 30, 2004
- VNUS Medical Technologies Announces Initial Public Offering - October 20, 2004
- MAP Pharmaceuticals Closes $30M Series B Financing - September 9, 2004
- Pharmion Corporation Launches Vidaza - July 6, 2004
- PTC Therapeutics Closes $50M Series E Financing - June 23, 2004
- Senomyx Announces Initial Public Offering - June 21, 2004
- NeoRx Acquires Compound from AnorMED - April 5, 2004
- Senomyx Files for Initial Public Offering - March 31, 2004
- PTC Therapeutics Raises $35M Financing - January 7, 2004
2003
- Reliant Pharmaceuticals Closes $252M Series D Financing - December 15, 2003
- Reliant Pharmaceuticals To Buy US Rights To Rythmol From Abbott - Novermber 20, 2003
- Pharmion Announces Initial Public Offering - November 06, 2003
- Oculex Pharmaceuticals Acquired by Allergan - October 14, 2003
- VNUS Medical Technologies Launches Closure PLUS - September 16, 2003
- Metabolex Raises $27M In Private Financing - August 8, 2003
- Genospectra and Bayer Announce Agreement - June 11, 2003
- Reliant Pharmaceuticals: FDA Approves Novartis’ Lescol and Lescol XL - May 29, 2003
- Oculex Announces Positive Clinical Results for Posurdex - May 8, 2003
- Reliant Pharmaceuticals Acquires DynaCirc and DynaCirc CR From Novartis - March 11, 2003
- Reliant Pharmaceuticals Receives FDA Approval for Innopran XL - March 6, 2003
- Maxia Pharmaceuticals Acquired by Incyte - February 19, 2003
- Epoch Biosciences Expands Minor Groove Binder Patent Portfolio - February 19, 2003
- Eos Biotechnology to be Acquired by Protein Design Labs - February 4, 2003
2002
- Oculex Pharmaceuticals Raises $50M Private Financing - October 22, 2002
- Epoch Ranked 107th Fastest Growing Technology Company - October 16, 2002
- Pharmion Completes $40M Private Financing - October 16, 2002
- Pharmion Launches First US Product - October 3, 2002
- Epoch and Amersham Announce Global Distribution Pact - July 30, 2002
- Itamar Medical Raises $8M Private Financing - July 15, 2002
- Senomyx Announces Agreement with the Coca-Cola Company - May 7, 2002
- Senomyx and Nestle Announce Agreement - May 6, 2002
- Omegatech Acquired by Martek - April 25, 2002
- Syntonix Completes $35.8M Series B Financing - April 16, 2002
- Phenomix Completes $32M Series A Financing
- Metabolex Announces Collaboration with Yamanouchi - March 20, 2002
- Senomyx Raises $36.8M Financing - March 11, 2002
- Bioseek Completes $8.4M Series A Financing - February 20, 2002
2001
- Reliant Pharmaceuticals and Alkermes Form Strategic Alliance - December 18, 2001
- Pharmion Secures $65M Private Financing - December 03, 2001
- PTC Therapeutics Raises Additional $40M - September 19, 2001
- Epocrates DocAlert Tapped by Astrazeneca - September 11, 2001
- Senomyx and Campbell Soup Company Announce Collaboration - April 23, 2001
- Symyx Announces Collaboration with ExxonMobil Chemical - January 29, 2001
- Syrrx Completes $54M Private Placement - January 08, 2001
2000
- Senomyx Announces Agreement with Kraft Foods - December 11, 2000
- SemBioSys Receives Broad US Patent for Oilbody Platform Technology - November 28, 2000
- Omegatech Announces FDA Allows Health Claim for DHA and EPA - November 13, 2000
- Epocrates Study Shows Physicians Avoid 2 Million Errors Annually - November 6, 2000
- SemBioSys Genetics Raises $16.5M Private Financing - Ocotber 20, 2000
- Symyx Technologies and Dow Chemical Company Enter Into Agreement - September 9, 2000
- Epocrates Network Tops 100K Users - August 8, 2000
- LJL BioSystems Acquired by Molecular Devices - June 8, 2000
- Lexicon Genetics Announces Pricing of Initial Public Offering - April 6, 2000
- Chemdex Stock Symbol Replaced by Ventro Corporation Stock Symbol - February 29, 2000
1999
- Symyx Commences Initial Public Offering - November 17, 1999
- Ambryx Raises $12.3M in One of Largest Biotechnology Financings in 1999 - October 25, 1999
- Chemdex Raises $112.5M in Initial Public Offering - July 27, 1999
- Chemdex Raises $30M in Latest Financing - April 5, 1999
- Bay City Capital Increases NeoRx Ownership - March 1, 1999
1998
- Pharmanex Acquired by Nu Skin Enterprises - October 6, 1998
- Medarex and Bay City Capital Announce Offer to Purchase Rights - July 27, 1998
